Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis

Lilian H. D. van Tuyl*, Maarten Boers, Willem F. Lems, Robert B. Landewe, Huub Han, S. van der Linden, Mart van de laar, Rene Westhovens, J. Christiaan van denderen, Marie-Louise Westedt, Andre J. Peeters, Piet Jacobs, Tom W J Huizinga, Hans van de Brink, Ben A. C. Dijkmans, Alexandre E. Voskuyl

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

INIS

Immunology and Microbiology